Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing
Its multi-pathway activity makes it one of the most widely referenced peptides in modern peptide science literature
50 , D543D552 (2022)
Key takeaways: PT-141 (Bremelanotide) targets sexual desire in the brain, not blood flow, unlike PDE5 inhibitors Triggers dopamine release in the hypothalamus, targeting low libido at its neurological source Effects onset in 45 to 60 minutes via injection or as little as 30 minutes via nasal spray, lasting several hours What is PT-141
This Medication Guide has been approved by the U.S
US$ 28.45
US$ 23.15
US$ 28.25
US$ 28.27
US$ 24.63
